CN109999056A - A kind of compound pellet and preparation method thereof containing a variety of amino acid, vitamine minerals - Google Patents
A kind of compound pellet and preparation method thereof containing a variety of amino acid, vitamine minerals Download PDFInfo
- Publication number
- CN109999056A CN109999056A CN201910250615.2A CN201910250615A CN109999056A CN 109999056 A CN109999056 A CN 109999056A CN 201910250615 A CN201910250615 A CN 201910250615A CN 109999056 A CN109999056 A CN 109999056A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- amino acid
- minerals
- capsule core
- variety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 64
- 239000011782 vitamin Substances 0.000 title claims abstract description 53
- 239000008188 pellet Substances 0.000 title claims abstract description 48
- 150000001875 compounds Chemical class 0.000 title claims abstract description 39
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 36
- 239000011707 mineral Substances 0.000 title claims abstract description 36
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 229940024606 amino acid Drugs 0.000 claims abstract description 64
- 239000002775 capsule Substances 0.000 claims abstract description 41
- 229940088594 vitamin Drugs 0.000 claims abstract description 30
- 229930003231 vitamin Natural products 0.000 claims abstract description 30
- 235000013343 vitamin Nutrition 0.000 claims abstract description 30
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 19
- 238000000926 separation method Methods 0.000 claims abstract description 17
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 12
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 11
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 8
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 8
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 8
- 239000004473 Threonine Substances 0.000 claims abstract description 8
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 7
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004474 valine Substances 0.000 claims abstract description 7
- 239000000725 suspension Substances 0.000 claims abstract description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 4
- 229960000310 isoleucine Drugs 0.000 claims abstract description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229930182817 methionine Natural products 0.000 claims abstract description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000001014 amino acid Nutrition 0.000 claims description 57
- 238000000576 coating method Methods 0.000 claims description 27
- 239000011248 coating agent Substances 0.000 claims description 26
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 17
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 12
- 239000011777 magnesium Substances 0.000 claims description 12
- 229910052749 magnesium Inorganic materials 0.000 claims description 12
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 12
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 11
- 229960002079 calcium pantothenate Drugs 0.000 claims description 11
- 239000011669 selenium Substances 0.000 claims description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 229910052711 selenium Inorganic materials 0.000 claims description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 8
- 230000004584 weight gain Effects 0.000 claims description 8
- 235000019786 weight gain Nutrition 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 7
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 7
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 7
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 7
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 7
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 7
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 7
- 229930003779 Vitamin B12 Natural products 0.000 claims description 7
- 229930003571 Vitamin B5 Natural products 0.000 claims description 7
- 229930003756 Vitamin B7 Natural products 0.000 claims description 7
- 229930003761 Vitamin B9 Natural products 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 7
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 7
- 229960005190 phenylalanine Drugs 0.000 claims description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 7
- 229960002898 threonine Drugs 0.000 claims description 7
- 235000019155 vitamin A Nutrition 0.000 claims description 7
- 239000011719 vitamin A Substances 0.000 claims description 7
- 235000019163 vitamin B12 Nutrition 0.000 claims description 7
- 239000011715 vitamin B12 Substances 0.000 claims description 7
- 235000009492 vitamin B5 Nutrition 0.000 claims description 7
- 239000011675 vitamin B5 Substances 0.000 claims description 7
- 235000011912 vitamin B7 Nutrition 0.000 claims description 7
- 239000011735 vitamin B7 Substances 0.000 claims description 7
- 235000019159 vitamin B9 Nutrition 0.000 claims description 7
- 239000011727 vitamin B9 Substances 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 6
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 229960004295 valine Drugs 0.000 claims description 6
- 235000019158 vitamin B6 Nutrition 0.000 claims description 6
- 239000011726 vitamin B6 Substances 0.000 claims description 6
- 229940011671 vitamin b6 Drugs 0.000 claims description 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 5
- 229930003448 Vitamin K Natural products 0.000 claims description 5
- 229960001230 asparagine Drugs 0.000 claims description 5
- 235000009582 asparagine Nutrition 0.000 claims description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 5
- 229960001231 choline Drugs 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 5
- 235000019168 vitamin K Nutrition 0.000 claims description 5
- 239000011712 vitamin K Substances 0.000 claims description 5
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 5
- 229940046010 vitamin k Drugs 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 239000011572 manganese Substances 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000011122 softwood Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 210000002784 stomach Anatomy 0.000 claims description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- 229930003451 Vitamin B1 Natural products 0.000 claims description 3
- 229930003471 Vitamin B2 Natural products 0.000 claims description 3
- 229930003537 Vitamin B3 Natural products 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- 235000004279 alanine Nutrition 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 235000009697 arginine Nutrition 0.000 claims description 3
- 229960002433 cysteine Drugs 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- 229960002885 histidine Drugs 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- 235000014304 histidine Nutrition 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 229960003136 leucine Drugs 0.000 claims description 3
- 229910052748 manganese Inorganic materials 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000013930 proline Nutrition 0.000 claims description 3
- 229960002477 riboflavin Drugs 0.000 claims description 3
- 238000005096 rolling process Methods 0.000 claims description 3
- 229960003495 thiamine Drugs 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 235000002374 tyrosine Nutrition 0.000 claims description 3
- 235000010374 vitamin B1 Nutrition 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 235000019164 vitamin B2 Nutrition 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 235000019160 vitamin B3 Nutrition 0.000 claims description 3
- 239000011708 vitamin B3 Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 238000001125 extrusion Methods 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- 238000005253 cladding Methods 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract description 3
- 239000004472 Lysine Substances 0.000 abstract description 3
- 206010021135 Hypovitaminosis Diseases 0.000 abstract description 2
- 238000009098 adjuvant therapy Methods 0.000 abstract description 2
- 239000000470 constituent Substances 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 230000036737 immune function Effects 0.000 abstract description 2
- 230000003993 interaction Effects 0.000 abstract description 2
- 208000000412 Avitaminosis Diseases 0.000 abstract 1
- 206010061291 Mineral deficiency Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 208000030401 vitamin deficiency disease Diseases 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 description 21
- 230000000694 effects Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- QAWLKTDBUQOFEF-UHFFFAOYSA-N 3-(4-bromophenyl)propanenitrile Chemical compound BrC1=CC=C(CCC#N)C=C1 QAWLKTDBUQOFEF-UHFFFAOYSA-N 0.000 description 4
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 4
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 4
- 229930064664 L-arginine Natural products 0.000 description 4
- 235000014852 L-arginine Nutrition 0.000 description 4
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 4
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- 235000013734 beta-carotene Nutrition 0.000 description 4
- 239000011648 beta-carotene Substances 0.000 description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 4
- 229960002747 betacarotene Drugs 0.000 description 4
- 229940047036 calcium ascorbate Drugs 0.000 description 4
- 235000010376 calcium ascorbate Nutrition 0.000 description 4
- 239000011692 calcium ascorbate Substances 0.000 description 4
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 4
- SEAWWLNESDNCGI-UHFFFAOYSA-K dicalcium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O SEAWWLNESDNCGI-UHFFFAOYSA-K 0.000 description 4
- 239000011773 ferrous fumarate Substances 0.000 description 4
- 235000002332 ferrous fumarate Nutrition 0.000 description 4
- 229960000225 ferrous fumarate Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 229960005321 mecobalamin Drugs 0.000 description 4
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 4
- 235000007672 methylcobalamin Nutrition 0.000 description 4
- 239000011585 methylcobalamin Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 229960002718 selenomethionine Drugs 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000003900 succinic acid esters Chemical class 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 4
- 235000005282 vitamin D3 Nutrition 0.000 description 4
- 239000011647 vitamin D3 Substances 0.000 description 4
- 229940021056 vitamin d3 Drugs 0.000 description 4
- 239000011746 zinc citrate Substances 0.000 description 4
- 235000006076 zinc citrate Nutrition 0.000 description 4
- 229940068475 zinc citrate Drugs 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- -1 antibody Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000219095 Vitis Species 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 108010042362 beta-Lipotropin Proteins 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- KQFUCKFHODLIAZ-UHFFFAOYSA-N manganese Chemical compound [Mn].[Mn] KQFUCKFHODLIAZ-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229910052718 tin Inorganic materials 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- GPWDPLKISXZVIE-UHFFFAOYSA-N cyclo[18]carbon Chemical compound C1#CC#CC#CC#CC#CC#CC#CC#CC#C1 GPWDPLKISXZVIE-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940071462 oralone Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention provides a kind of compound pellets containing a variety of amino acid, vitamine minerals, including capsule core and the packet medicine clothing being wrapped in outside capsule core, separation layer is equipped between the capsule core and packet medicine clothing, the capsule core includes vitamin, minerals and auxiliary material, the packet medicine clothing is the amino acid of powder or suspension formation, and the amino acid includes leucine, isoleucine, valine, lysine, threonine, methionine, tryptophan, phenylalanine.The compound pellet converges in a variety of amino acid, multivitamin and several mineral materials three categories ingredient in pellet, form a complete entirety, ensure homogeneity, other ingredients such as amino acid and vitamin, minerals are separated by separation layer simultaneously, avoid the interaction between different constituents, improve the stability of preparation, it can be used for the adjuvant treatment of disease caused by amino acid, vitamin and mineral deficiency, and the nutrition and health care with sub-health population Health restoration after being ill, facilitate the immune function for enhancing human body.
Description
Technical field
The invention belongs to medicines and health protection food technology fields, and in particular to a kind of containing a variety of amino acid, vitamine minerals
Compound pellet and preparation method thereof.
Background technique
Amino acid is the base substance of protein needed for constituting human nutrition, is that one kind contains basic amine group and acidic carboxypolymer
Organic compound, the amino acid of constitutive protein matter is largely a-amino acid, is planted for 20.Amino acid is to constitute protein
Basic unit is played a significant role by metabolism in human body, such as synthetic tissue protein, becomes acid, hormone, antibody, creatine
Deng containing ammoniacal substance, it is changed into carbohydrate and fat, is oxidized to carbon dioxide and water and urea, generate energy etc.;It is different
Some differences of its physiological action of amino acid, human body often take compound rear use when supplementing amino acid, at present amino acid oral one
As be 18~20 kinds, include amino acid and nonessential amino acid needed by human.
Vitamin also known as vitamin, for popular, that is, the substance to sustain life is to maintain human life activity necessary one
Type organic matter is also to maintain the important active substances of human health.The content of vitamin in vivo is seldom, but indispensable,
This kind of compound cannot generally synthesize in vivo or synthetic quantity religion is few, cannot meet the needs, the needs of human body are mainly from natural
Food.It is divided into fat-soluble and water-soluble two class according to the chemical property of vitamin, liposoluble vitamin is in addition to the content in food
It influences outside supply amount, it is necessary to fat absorption, so fat food also influences fat soluble vitamin absorption;Water soluble vitamin
Food supply is then relied primarily on, if eaten food vitamin content is very few, will appear hypovitaminosis, normal human is not to
Demand with vitamin is different, and certain vitamin is required supplementation with when necessary.
Human elementary (minerals) refers to the chemical element of group adult body, the natural environment background phase of it and life location
It adapts to, generallys include three classes: macroelement, microelement and age element.Wherein microelement is the various element of group adult body
In account for the element of human total weight's a ten thousandth, they are total to account for the 0.05% of human total weight, and microelement has iron, zinc, copper
More than 40 clocks such as cobalt, molybdenum, violent, chromium, selenium, silicon, fluorine, vanadium, iodine, strontium, bromine, boron, barium, arsenic, lithium, nickel, tin;According to body to microelement
Need situation to be divided into essential trace element and Non-necessary Trace Elements again.Maintain the indispensable member of human normal vital movement
It is called usually as essential trace element, the essential trace element that majority generally acknowledge at present has: iron (Fe), copper (Cu), zinc (Zn), cobalt
(Co), molybdenum (Mo), selenium (Se), iodine (I), manganese (Mn), silicon (Si), vanadium (V), tin (Sn), fluorine (F), 13 kinds of nickel (Ni);Macroelement
The element that human total weight's a ten thousandth or more is accounted for for content, as human body is oxygen-containing 65%, carbon 18%, hydrogen 10%, nitrogen 3%, calcium
1.5%, phosphorus 1%, potassium 0.35%, sulphur 0.25%, sodium 0.15%, chlorine 0.15%, magnesium 0.05%, they are referred to as human body constant member
Element.Whether microelement or macroelement maintain metabolism to the trophism that all has of human body, or even maintain life
Life has vital effect.
And in the prior art and have no by a variety of amino acid, multivitamin and a variety of human elementaries (minerals) by be suitable for
The report of the compound pellet of formula composition.Domestic patent CN100364528C be related to be amino acid and vitamin composition pellet
Capsule, preparation method are that various pellets are respectively prepared in amino acid and vitamin, remix filling capsule;This production method can not
Amino acid and vitamin are converged in the same pellet, cannot ensure the homogeneity of each ingredient in final preparation completely.
Summary of the invention
The purpose of the present invention is overcoming contained nutritional ingredient in existing compound pellet few, and the nutrition such as amino acid, vitamin
Ingredient separates pill, and the problem of cannot ensure each compositional uniformity in final preparation.
For this purpose, the present invention provides a kind of compound pellet containing a variety of amino acid, vitamine minerals, including capsule core and packet
The packet medicine clothing being rolled in outside capsule core, between the capsule core and packet medicine clothing be equipped with separation layer, the capsule core include vitamin, minerals and
Auxiliary material, the packet medicine clothing are the amino acid of powder or suspension formation, and the amino acid includes leucine, isoleucine, figured silk fabrics ammonia
Acid, lysine, threonine, methionine, tryptophan, phenylalanine.
Further, the vitamin includes vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, dimension
Raw element B6, vitamin B7, Vitamin B9, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, in choline at least
12 kinds.
Further, the minerals include zinc, calcium, iron, selenium, magnesium, at least five kinds of human elementaries in manganese.
Further, the auxiliary material includes starch, microcrystalline cellulose, lactose.
Further, the amino acid further includes histidine, arginine, alanine, asparatate, cysteine, paddy
At least one of propylhomoserin, proline, tyrosine, glycine, serine, asparagine, glutamine.
Further, the separation layer is made of hydroxypropyl methyl cellulose or stomach dissolution type coating powder, solid content 5
~10%.
Further, one layer of exterior coating is also enclosed with outside the packet medicine clothing, the exterior coating uses hydroxypropyl methyl
Cellulose, hydroxypropyl cellulose, ethyl cellulose or coating powder are made.
In addition, the present invention also provides the preparation method of the above-mentioned compound pellet containing a variety of amino acid, vitamine minerals,
Include the following steps:
1) vitamin, minerals are weighed by recipe quantity, is uniformly mixed after pulverizing and sieving with auxiliary material, added water or containing adhesive
Softwood is made in aqueous solution mixing, and by extrusion-method for rolling circle, capsule core is made, spare;
2) a variety of amino acid are weighed by recipe quantity, is micronized using airslide disintegrating mill, add water or add sticky auxiliary material
Amino acid capsule core annex solution is prepared in homogeneous mixing, spare;
3) insolated layer materials are added water and stirred and is configured to the barrier gown liquid that solid content is 8%, it is spare;
4) capsule core for obtaining step 1) is after fluidized bed drying, using the barrier gown liquid of step 3) in capsule core outer surface
It is coated, forms one layer of separation layer;
5) the amino acid capsule core annex solution that step 2) obtains is sprayed the capsule core that feeding to step 4) obtains with atomised form
On, one layer of packet medicine clothing containing amino acid is formed to get compound pellet.
Further, the preparation method of above-mentioned compound pellet further includes step 6), in the packet medicine clothing of step 5) compound pellet
One layer of exterior coating of outer package.
Further, separation layer weight gain 10~20% in the step 4), exterior coating weight gain 0~10% in step 6).
Compared with prior art, beneficial effects of the present invention:
(1) this compound pellet containing a variety of amino acid, vitamine minerals provided by the invention is by a variety of amino acid, more
Kind vitamin and a variety of human elementaries (minerals) three categories ingredient converge in pellet, form a complete entirety, it is ensured that
One property, while being separated the coating containing amino acid and vitamin, mineral composition by separation layer, avoid different constituents
Between interaction, improve the stability of its preparation.
(2) this compound pellet good appearance provided by the invention, and good fluidity need to only be processed just through simple formulations
Granule, capsule, tablet can be made, it is not necessary that glidant is added, so that it may directly be loaded in hollow softgel shell, capsule is made
Agent;Granule is made with auxiliary materials such as sweetener, suspending agents;With the preferable auxiliary material of mobility, mixes direct tablet compressing and be obtained with
Tablet has good market application prospect.
(3) this compound pellet provided by the invention can be used for amino acid, vitamin and human elementary (minerals) shortage
The adjuvant treatment of caused disease, and the nutrition and health care with sub-health population Health restoration after being ill help to enhance human body
Immune function.
Specific embodiment
The following is a clear and complete description of the technical scheme in the embodiments of the invention, it is clear that described embodiment
Only a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, the common skill in this field
Art personnel all other embodiment obtained without making creative work belongs to the model that the present invention protects
It encloses.
It present embodiments provides a kind of compound pellet containing a variety of amino acid, vitamine minerals, including capsule core and is wrapped in
Packet medicine clothing outside capsule core, is equipped with separation layer between the capsule core and packet medicine clothing, the capsule core includes vitamin, minerals and auxiliary
Material, the packet medicine clothing are the amino acid of powder or suspension formation, the amino acid include leucine, isoleucine, valine,
Lysine, threonine, methionine, tryptophan, phenylalanine.Wherein, separation layer is mainly used for amino acid and other compositions
Isolation, avoids interacting, and improves the stability of the compound pellet preparations, and main material uses hydroxypropyl methyl fiber
Element or the stomach dissolution type coating powder for directly buying such as Ka Lekang.
Specifically, the amino acid further includes histidine, arginine, alanine, asparatate, cysteine, paddy ammonia
At least one of acid, proline, tyrosine, glycine, serine, asparagine, glutamine.The characteristic and work of each amino acid
With as shown in table 1.The vitamin includes vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin
B6, vitamin B7, Vitamin B9, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, at least 12 in choline
Kind, the characteristic of each vitamin and effect are as shown in table 2.The minerals include zinc, calcium, iron, selenium, magnesium, at least five kinds of people in manganese
Element of volume, the carrier of each element are to have listed the various carriers used, and each element common carrier and effect are as shown in table 3.Institute
Stating auxiliary material includes starch, microcrystalline cellulose, lactose.
A kind of embodiment of optimization, the packet medicine clothing are also enclosed with one layer of exterior coating outside, which is common
The coating that water not readily dissolves, main function are pellet short time (3~5min) non-breakable dissolutions in water, are not only improved anti-
Tide, when being also beneficial to form suspension in water with granule made of the pellet, ingredient is not easy to dissolve out, and has to mouthfeel is improved
Important function;Its material is using hydroxypropyl methyl cellulose, hydroxypropyl cellulose, ethyl cellulose or directly buys commercially available coating
Powder, such as reinforce damp-proof and be coated pre- pulvis, HPC aqueous dispersion, EC aqueous dispersion.
Table 1: aminoacids characteristic and effect
Table 2: vitamin characteristic and effect
Table 3: human elementary common carrier and effect
Illustrate the prescription and preparation method thereof of this compound pellet of the present invention below by specific embodiment.
Embodiment 1:
A kind of compound pellet containing a variety of amino acid, vitamine minerals is present embodiments provided, prescription is as follows:
L-Leu 42mg, l-Isoleucine 30mg, Valine 30mg, l-Lysine hydrochloride 45mg, L-threonine
21mg, l-methionine 39mg, L-Trp 10.5mg, L-phenylalanine 40mg, L- histidine monohydrochloride 30mg, L-arginine
32mg, l-Alanine 24mg, ASPARTIC ACID 16mg, L- cysteine hydrochloride 4.5mg, Pidolidone 14mg, L-PROLINE
7mg, l-tyrosine 2mg, glycine 22mg, Serine 5mg, asparagine 12mg, glutamine 14mg;
Vitamin A (beta carotene) 625IU, thiamine hydrochloride (vitamin B1) 7.5mg, riboflavin (vitamin B2)
7.5mg, niacinamide (vitamin B3) 15mg, calcium pantothenate (vitamin B5) 10mg, puridoxine hydrochloride (vitamin B6) 7.5mg, life
Object element (vitamin B7) 0.5mg, folic acid (Vitamin B9) 100mg, Mecobalamin (vitamin B12) 40mcg, Calcium Ascorbate (dimension
Raw element C) 30mg, Vitamin D3 (vitamine D3) 65IU, d- alpha-tocofecol succinic acid ester (vitamin E) 50IU, vitamin K
30mcg, lipotropin (choline) 4mg;
Calcium citrate (calcium) 200mg, Magnesium Asparticum (magnesium) 150mg, ferrous fumarate (iron) 7.5mg, zinc citrate
45 μ g of (zinc) 6mg, L- selenomethionine (selenium), grape acid manganese (manganese) 8mg.
This compound pellet of the present embodiment the preparation method is as follows:
1. weighing various vitamins and human elementary carrier (minerals) by above-mentioned recipe quantity, it crushed 60~80 meshes,
It is uniformly mixed again with supplementary product starch, microcrystalline cellulose, lactose, adds 5%PVPK30Appropriate aqueous solution, softwood processed.
2. above-mentioned softwood is extruded into the bar of 1~3cm using 20 mesh screens through extruder;Bar is placed in rolling
In circular knitting machine, engine speed is adjusted in 800~1000rpm, throws and justifies 5~8min, after uniform capsule core to be formed, discharging is set
It is spare in drying in fluidized bed.
3. preparing barrier gown liquid, the stomach dissolution type coating powder of Ka Lekang is added into water, the barrier gown of solid content 8% is prepared in stirring
Liquid is coated the capsule core of above-mentioned drying in fluidized bed, after pellet weight gain 20%, stops coating, thus outside capsule core
Form one layer of separation layer.
4. weighing various amino acid by above-mentioned recipe quantity, through airslide disintegrating mill, amino acid micronizing materials are crushed to obtain, with
5%PVPK30Appropriate aqueous solution is configured to amino acid capsule core annex solution, through peristaltic pump, to above-mentioned spacer layer coating in fluidized bed
Capsule core afterwards carries out spraying feeding, up to amino acid capsule core annex solution whole feeding to capsule core surface.
5. preparing exterior coating liquid, the pre- pulvis of damp-proof coating will be reinforced and add water, the outer coatings of solid content 8% are prepared in stirring
Layer liquid, is coated above-mentioned capsule core in fluidized bed, after pellet weight gain 10%, stops coating, dry discharging, thus in ball
One layer of exterior coating is formed outside core.
6. being packed after taking above-mentioned pellet to carry out intermediate inspection to obtain the final product.
7. when necessary, as needed, processing through simple formulations technique, which is made the mouths such as granule or capsule, tablet
Formulation.
Embodiment 2:
A kind of compound pellet containing a variety of amino acid, vitamine minerals is present embodiments provided, prescription is as follows:
L-Leu 42mg, l-Isoleucine 30mg, Valine 30mg, l-Lysine hydrochloride 45mg, L-threonine
21mg, l-methionine 39mg, L-Trp 10.5mg, L-phenylalanine 40mg, L- histidine monohydrochloride 30mg, L-arginine
32mg, l-Alanine 24mg, ASPARTIC ACID 16mg, L- cysteine hydrochloride 4.5mg, Pidolidone 14mg, L-PROLINE
7mg, l-tyrosine 2mg, glycine 22mg, Serine 5mg, asparagine 12mg, glutamine 14mg;
Vitamin A (beta carotene) 625IU, thiamine hydrochloride (vitamin B1) 7.5mg, riboflavin (vitamin B2)
7.5mg, niacinamide (vitamin B3) 15mg, calcium pantothenate (vitamin B5) 10mg, puridoxine hydrochloride (vitamin B6) 7.5mg, life
Object element (vitamin B7) 0.5mg, folic acid (Vitamin B9) 100mg, Mecobalamin (vitamin B12) 40mcg, Calcium Ascorbate (dimension
Raw element C) 30mg, Vitamin D3 (vitamine D3) 65IU, d- alpha-tocofecol succinic acid ester (vitamin E) 50IU;
Calcium citrate (calcium) 200mg, Magnesium Asparticum (magnesium) 150mg, ferrous fumarate (iron) 7.5mg, zinc citrate
45 μ g of (zinc) 6mg, L- selenomethionine (selenium).
The preparation method of this compound pellet of the present embodiment with above-described embodiment 1, the difference is that, separation layer is consolidated
Content is 5%, and separation layer weight gain 20% is free of exterior coating.
Embodiment 3:
A kind of compound pellet containing a variety of amino acid, vitamine minerals is present embodiments provided, prescription is as follows:
L-Leu 42mg, l-Isoleucine 30mg, Valine 30mg, l-Lysine hydrochloride 45mg, L-threonine
21mg, l-methionine 39mg, L-Trp 10.5mg, L-phenylalanine 40mg, L- histidine monohydrochloride 30mg, L-arginine
32mg, l-Alanine 24mg, ASPARTIC ACID 16mg, L- cysteine hydrochloride 4.5mg, Pidolidone 14mg, L-PROLINE
7mg, l-tyrosine 2mg, glycine 22mg, Serine 5mg;
Vitamin A (beta carotene) 625IU, thiamine hydrochloride (vitamin B1) 7.5mg, riboflavin (vitamin B2)
7.5mg, niacinamide (vitamin B3) 15mg, calcium pantothenate (vitamin B5) 10mg, puridoxine hydrochloride (vitamin B6) 7.5mg, life
Object element (vitamin B7) 0.5mg, folic acid (Vitamin B9) 100mg, Mecobalamin (vitamin B12) 40mcg, Calcium Ascorbate (dimension
Raw element C) 30mg, Vitamin D3 (vitamine D3) 65IU, d- alpha-tocofecol succinic acid ester (vitamin E) 50IU;
Calcium citrate (calcium) 200mg, Magnesium Asparticum (magnesium) 150mg, ferrous fumarate (iron) 7.5mg, zinc citrate
45 μ g of (zinc) 6mg, L- selenomethionine (selenium).
The preparation method of this compound pellet of the present embodiment with above-described embodiment 1, the difference is that, separation layer is consolidated
Content is 10%, separation layer weight gain 100%, exterior coating weight gain 5%.
Embodiment 4:
A kind of compound pellet containing a variety of amino acid, vitamine minerals is present embodiments provided, prescription is as follows:
L-Leu 42mg, l-Isoleucine 30mg, Valine 30mg, l-Lysine hydrochloride 45mg, L-threonine
21mg, l-methionine 39mg, L-Trp 10.5mg, L-phenylalanine 40mg, L- histidine monohydrochloride 30mg, L-arginine
32mg, l-Alanine 24mg, ASPARTIC ACID 16mg, L- cysteine hydrochloride 4.5mg, Pidolidone 14mg, L-PROLINE
7mg, l-tyrosine 2mg, glycine 22mg, Serine 5mg;
Vitamin A (beta carotene) 625IU, thiamine hydrochloride (vitamin B1) 7.5mg, riboflavin (vitamin B2)
7.5mg, niacinamide (vitamin B3) 15mg, calcium pantothenate (vitamin B5) 10mg, puridoxine hydrochloride (vitamin B6) 7.5mg, life
Object element (vitamin B7) 0.5mg, folic acid (Vitamin B9) 100mg, Mecobalamin (vitamin B12) 40mcg, Calcium Ascorbate (dimension
Raw element C) 30mg, Vitamin D3 (vitamine D3) 65IU, d- alpha-tocofecol succinic acid ester (vitamin E) 50IU, vitamin K
30mcg, lipotropin (choline) 4mg;
Calcium citrate (calcium) 200mg, Magnesium Asparticum (magnesium) 150mg, ferrous fumarate (iron) 7.5mg, zinc citrate
45 μ g of (zinc) 6mg, L- selenomethionine (selenium), grape acid manganese (manganese) 8mg.
The preparation method of this compound pellet of the present embodiment is the same as above-described embodiment 1.
The foregoing examples are only illustrative of the present invention, does not constitute the limitation to protection scope of the present invention, all
It is within being all belonged to the scope of protection of the present invention with the same or similar design of the present invention.
Claims (10)
1. a kind of compound pellet containing a variety of amino acid, vitamine minerals, it is characterised in that: including capsule core and be wrapped in capsule core
Outer packet medicine clothing is equipped with separation layer between the capsule core and packet medicine clothing, the capsule core includes vitamin, minerals and auxiliary material, institute
The amino acid that packet medicine clothing is powder or suspension formation is stated, the amino acid includes leucine, isoleucine, valine, relies ammonia
Acid, threonine, methionine, tryptophan, phenylalanine.
2. the compound pellet as described in claim 1 containing a variety of amino acid, vitamine minerals, it is characterised in that: the dimension life
Element include vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B7, Vitamin B9,
Vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, at least 12 kinds in choline.
3. the compound pellet as described in claim 1 containing a variety of amino acid, vitamine minerals, it is characterised in that: the mineral
Matter includes zinc, calcium, iron, selenium, magnesium, at least five kinds of human elementaries in manganese.
4. the compound pellet as described in claim 1 containing a variety of amino acid, vitamine minerals, it is characterised in that: the auxiliary material
Including starch, microcrystalline cellulose, lactose.
5. the compound pellet as described in claim 1 containing a variety of amino acid, vitamine minerals, it is characterised in that: the amino
Acid further include histidine, arginine, alanine, asparatate, cysteine, glutamic acid, proline, tyrosine, glycine,
At least one of serine, asparagine, glutamine.
6. the compound pellet as described in claim 1 containing a variety of amino acid, vitamine minerals, it is characterised in that: the isolation
Layer is made of hydroxypropyl methyl cellulose or stomach dissolution type coating powder, and solid content is 5~10%.
7. the compound pellet as described in claim 1 containing a variety of amino acid, vitamine minerals, it is characterised in that: the packet medicine
One layer of exterior coating is also enclosed with outside clothing, the exterior coating is fine using hydroxypropyl methyl cellulose, hydroxypropyl cellulose, ethyl
Dimension element or coating powder are made.
8. the preparation method of compound pellet as described in any one of claims 1 to 7, characterized by the following steps:
1) vitamin, minerals are weighed by recipe quantity, is uniformly mixed after pulverizing and sieving with auxiliary material, added water or water-soluble containing adhesive
Softwood is made in liquid mixing, and by extrusion-method for rolling circle, capsule core is made, spare;
2) a variety of amino acid are weighed by recipe quantity, is micronized using airslide disintegrating mill, add water or add sticky auxiliary material homogeneous
Amino acid capsule core annex solution is prepared in mixing, spare;
3) insolated layer materials are added water and stirred and is configured to the barrier gown liquid that solid content is 8%, it is spare;
4) capsule core for obtaining step 1) is carried out using the barrier gown liquid of step 3) in capsule core outer surface after fluidized bed drying
Cladding, forms one layer of separation layer;
5) the amino acid capsule core annex solution that step 2) obtains is sprayed in the capsule core that feeding to step 4) obtains with atomised form, shape
At one layer of packet medicine clothing containing amino acid to get compound pellet.
9. the preparation method of compound pellet as claimed in claim 8, it is characterised in that: it further include step 6), it is multiple in step 5)
One layer of exterior coating is wrapped up outside the packet medicine clothing of square pellet.
10. the preparation method of compound pellet as claimed in claim 9, it is characterised in that: separation layer increases weight in the step 4)
10~20%, exterior coating weight gain 0~10% in step 6).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910250615.2A CN109999056A (en) | 2019-03-29 | 2019-03-29 | A kind of compound pellet and preparation method thereof containing a variety of amino acid, vitamine minerals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910250615.2A CN109999056A (en) | 2019-03-29 | 2019-03-29 | A kind of compound pellet and preparation method thereof containing a variety of amino acid, vitamine minerals |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109999056A true CN109999056A (en) | 2019-07-12 |
Family
ID=67168958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910250615.2A Pending CN109999056A (en) | 2019-03-29 | 2019-03-29 | A kind of compound pellet and preparation method thereof containing a variety of amino acid, vitamine minerals |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109999056A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113080465A (en) * | 2021-04-23 | 2021-07-09 | 江苏金维氨生物工程有限公司 | Functional compound amino acid additive |
WO2022032804A1 (en) * | 2020-08-11 | 2022-02-17 | 河北科星药业有限公司 | Compound amino acid enteric-coated tablet for dogs and preparation method therefor |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101732261A (en) * | 2010-01-20 | 2010-06-16 | 福州闽海药业有限公司 | Stable type compound pellet, preparation method thereof and capsule containing same |
WO2010071541A1 (en) * | 2008-12-17 | 2010-06-24 | Igelösa Nutrition Science Ab | Nutritional supplement with specific amino acid profile |
CN102038691A (en) * | 2009-10-12 | 2011-05-04 | 杭州赛利药物研究所有限公司 | Composite preparation of vitamins and amino acids and preparation method thereof |
-
2019
- 2019-03-29 CN CN201910250615.2A patent/CN109999056A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010071541A1 (en) * | 2008-12-17 | 2010-06-24 | Igelösa Nutrition Science Ab | Nutritional supplement with specific amino acid profile |
CN102038691A (en) * | 2009-10-12 | 2011-05-04 | 杭州赛利药物研究所有限公司 | Composite preparation of vitamins and amino acids and preparation method thereof |
CN101732261A (en) * | 2010-01-20 | 2010-06-16 | 福州闽海药业有限公司 | Stable type compound pellet, preparation method thereof and capsule containing same |
Non-Patent Citations (1)
Title |
---|
姜辉 等: "包衣甘氨酸亚铁微丸的制备及其性能研究", 《安徽化工》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022032804A1 (en) * | 2020-08-11 | 2022-02-17 | 河北科星药业有限公司 | Compound amino acid enteric-coated tablet for dogs and preparation method therefor |
CN113080465A (en) * | 2021-04-23 | 2021-07-09 | 江苏金维氨生物工程有限公司 | Functional compound amino acid additive |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4742037B2 (en) | Calcium carbonate granules | |
KR101535310B1 (en) | Improved stability in vitamine and mineral supplements | |
CN102038691B (en) | Composite preparation of vitamins and amino acids and preparation method thereof | |
RU2414211C2 (en) | Composition with prolonged release of active substance, method of its obtaining and application | |
CN109999056A (en) | A kind of compound pellet and preparation method thereof containing a variety of amino acid, vitamine minerals | |
WO2012133658A1 (en) | Bottled beverage comprising cap containing dietary supplement and bottle filled with dispersion medium for dietary supplement | |
CN102125179A (en) | Soft capsule nutritional supplement applicable to piglets and preparation method thereof | |
CN106420629B (en) | Branched-amino acid supplement and its preparation method and application | |
CN109172531A (en) | A kind of composite calcium carbonate/vitamin D3Tablet and preparation method thereof | |
CN107625786A (en) | A kind of calcium carbonate vitamin D3Composition and its anhydrous swallow particle | |
JP2004242509A (en) | Food containing coenzyme q10 and amino acid | |
CN102048750A (en) | Amino acid-contained complex multivitamin microemulsion preparation and preparation method thereof | |
RU2410085C2 (en) | Oral composition with controlled release biologically active substances | |
ITBO20120226A1 (en) | COMPOSITIONS INCLUDING ALPINE-KETOGLUTARATE ORNITINE, PROCESSES FOR THEIR ACHIEVEMENT AND THEIR USE. | |
CN102356826B (en) | Multi-vitamin gunk for pigs and production process thereof | |
CN106619565A (en) | Arginine preparation and preparation method and application thereof | |
CN101156837A (en) | A method for preparing compound recipe amino acid vitamin micro pill capsule | |
JP2014047183A (en) | Granule and manufacturing method of the same, and tablet and manufacturing method of the same | |
JP2008162955A (en) | Valine-containing high density granular agent | |
CN112791101B (en) | Multivitamin mineral tablet and preparation method thereof | |
CN108185439A (en) | A kind of health food for supplementing zinc selenium element and preparation method thereof | |
CN104688763A (en) | Lysine-vitamin pharmaceutical composition containing chiral isocompounds and use thereof | |
JP7353103B2 (en) | Nutritional supplement composition and method for producing the same, method for suppressing unpleasant odor of a nutritional supplement composition, and composition for suppressing unpleasant odor of a nutritional supplement composition | |
US20230158066A1 (en) | Encapsulated carbonyl iron salt compositions and process thereof | |
JP5434907B2 (en) | Nutritional improvement composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190712 |